Replimune Group, Inc.
For the period ended Sep 30, 2025. Filed Nov 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 6, 2025
REPL$22.26+3.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
(Amounts in thousands, except share and per share amounts)
| September 30, 2025 | March 31, 2025 | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $102,298 | $111,119 |
| Short-term investments | 221,346 | 372,685 |
| Research and development incentives receivable | 1,806 | 3,725 |
| Prepaid expenses and other current assets | 8,299 | 8,351 |
| Total current assets | 333,749 | 495,880 |
| Property, plant and equipment, net | 14,711 | 13,739 |
| Research and development incentives receivable, non-current | 799 | — |
| Restricted cash | 1,705 | 1,703 |
| Other non-current assets | 1,200 | 1,200 |
| Right-of-use asset - operating leases | 3,692 | 3,998 |
| Right-of-use asset - financing leases | 33,594 | 34,808 |
| Total assets | $389,450 | $551,328 |
| Liabilities and Stockholders' Equity | ||
| Current liabilities: | ||
| Accounts payable | $6,404 | $12,463 |
| Accrued expenses and other current liabilities | 42,445 | 45,916 |
| Operating lease liabilities, current | 1,210 | 1,184 |
| Financing lease liabilities, current | 2,841 | 2,799 |
| Total current liabilities | 52,900 | 62,362 |
| Operating lease liabilities, non-current | 2,723 | 3,076 |
| Financing lease liabilities, non-current | 22,344 | 22,729 |
| Long term debt, net of discount | 47,206 | 46,377 |
| Other liabilities, non-current | 941 | 941 |
| Total liabilities | $126,114 | $135,485 |
| Commitments and contingencies (Note 14) | ||
| Stockholders' equity | ||
| Common stock, $0.001 par value; 150,000,000 shares authorized as of September 30, 2025 and March 31, 2025; 78,403,255 and 77,085,024 shares issued and outstanding as of September 30, 2025 and March 31, 2025, respectively | 78 | 77 |
| Additional paid-in capital | 1,376,507 | 1,358,897 |
| Accumulated deficit | (1,118,372) | (948,579) |
| Accumulated other comprehensive income | 5,123 | 5,448 |
| Total stockholders' equity | 263,336 | 415,843 |
| Total liabilities and stockholders' equity | $389,450 | $551,328 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.